156 related articles for article (PubMed ID: 3276492)
41. [Thymic hormone treatment of acute and chronic respiratory infections in the elderly].
Agostinelli M; Zaia AM; Fiorentini A; Stecconi R; Fabris N; Scalise G
Recenti Prog Med; 1989; 80(7-8):438-41. PubMed ID: 2682857
[TBL] [Abstract][Full Text] [Related]
42. [Treatment with thymopentine of chronic bronchitis in elderly patients during seasonal prophylaxis].
Santagata A
Clin Ter; 1990 Feb; 132(4):249-54. PubMed ID: 2140311
[TBL] [Abstract][Full Text] [Related]
43. Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients.
Przybilla B; Burg G; Schmoeckel C; Braun-Falco O
Acta Derm Venereol; 1983; 63(6):524-9. PubMed ID: 6198843
[TBL] [Abstract][Full Text] [Related]
44. Thymopentin (TP-5) therapy during lymphadenopathy syndrome (LAS/ARC): preliminary report.
Costigliola P; Ricchi E; Colangeli V; Pintori C; Boni P; Chiodo F
J Exp Pathol; 1987; 3(4):705-12. PubMed ID: 3331653
[TBL] [Abstract][Full Text] [Related]
45. Safety of thymopentin. Data from European clinical studies.
Weiss P; Stocker H
Surv Immunol Res; 1985; 4 Suppl 1():149-54. PubMed ID: 3898288
[TBL] [Abstract][Full Text] [Related]
46. Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis.
Veys EM; Huskisson EC; Rosenthal M; Vischer TL; Mielants H; Thrower PA; Scott J; Ott H; Scheijgrond H; Symoens J
Ann Rheum Dis; 1982 Oct; 41(5):441-3. PubMed ID: 6751241
[TBL] [Abstract][Full Text] [Related]
47. [The protective action of thymopentin on stress damage to the stomach].
Deviatkina TA; Tarasenko LM; Klusha VE; Tsebrzhinskiĭ OI; Mutsenietse RK
Biull Eksp Biol Med; 1989 Jun; 107(6):673-5. PubMed ID: 2676006
[TBL] [Abstract][Full Text] [Related]
48. Thymopentin treatment in AIDS and pre-AIDS patients.
Clumeck N; Cran S; Van de Perre P; Mascart-Lemone F; Duchateau J; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():58-62. PubMed ID: 3898293
[TBL] [Abstract][Full Text] [Related]
49. Immunomodulation with thymopentin in humans.
Bolla K; Duchateau J; Delespesse G; Servais G
Int J Clin Pharmacol Res; 1984; 4(6):431-8. PubMed ID: 6398312
[TBL] [Abstract][Full Text] [Related]
50. Thymopentin treatment in a patient with pluriorificial pyoderma vegetans.
Simon M; Djawari D; Horstein OP; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():125-8. PubMed ID: 3898284
[TBL] [Abstract][Full Text] [Related]
51. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
[No Abstract] [Full Text] [Related]
52. [Model for acquired immunodeficiency caused by anesthesia and surgical procedures. Effect of treatment with thymopoietin pentapeptide (TP5)].
Auteri A; D'Aniello C; Falotico N; Saletti M; Di Perri T
Recenti Prog Med; 1986 Sep; 77(9):423-8. PubMed ID: 3541085
[No Abstract] [Full Text] [Related]
53. Thymopentin in the treatment of severe alopecia areata.
Tosti A; Manuzzi P; Gasponi A
Dermatologica; 1988; 177(3):170-4. PubMed ID: 3049174
[TBL] [Abstract][Full Text] [Related]
54. [Use of thymopentin in the therapy of recurrent oral ulcers].
Robotti MP; Fabbri G; Baldin C; Faccioli G; Ciaffoni S
Minerva Stomatol; 1988 Jun; 37(6):497-503. PubMed ID: 3050443
[No Abstract] [Full Text] [Related]
55. Thymopentin in dermatology.
Haneke E
Curr Probl Dermatol; 1989; 18():283-9. PubMed ID: 2663371
[No Abstract] [Full Text] [Related]
56. Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis.
Weisman MH
Clin Ther; 1986; 8(4):427-38. PubMed ID: 3524843
[TBL] [Abstract][Full Text] [Related]
57. [Possible selective effects of thymopentin on polymorphonuclear activity in patients undergoing dialysis].
Salvati F
Recenti Prog Med; 1989 Sep; 80(9):499. PubMed ID: 2687987
[No Abstract] [Full Text] [Related]
58. [Intra-lesional beta-interferon in combination with systemic thymopentin. Evaluation of results in 35 cases of CIN III and 2 cases of VAIN associated with HPV].
Osnengo G; Maina G; Gordini G; Durando A; Bertone C
Minerva Ginecol; 1990 Apr; 42(4):123-8. PubMed ID: 2163035
[TBL] [Abstract][Full Text] [Related]
59. Immunomodulation in infection caused by human immunodeficiency virus.
Phair JP
J Lab Clin Med; 1989 Feb; 113(2):135-6. PubMed ID: 2644386
[No Abstract] [Full Text] [Related]
60. Thymopentin treatment of selective IgA deficiency.
Fiorilli M; Quinti I; Russi G; Seminara R; Ensoli B; Aiuti F
Surv Immunol Res; 1985; 4 Suppl 1():129-34. PubMed ID: 3898285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
